DK1212334T3 - Oligosaccharidderivater fra ribose-ribitol-fosfat og vacciner indeholdende disse - Google Patents

Oligosaccharidderivater fra ribose-ribitol-fosfat og vacciner indeholdende disse

Info

Publication number
DK1212334T3
DK1212334T3 DK00956040T DK00956040T DK1212334T3 DK 1212334 T3 DK1212334 T3 DK 1212334T3 DK 00956040 T DK00956040 T DK 00956040T DK 00956040 T DK00956040 T DK 00956040T DK 1212334 T3 DK1212334 T3 DK 1212334T3
Authority
DK
Denmark
Prior art keywords
ribose
vaccines containing
oligosaccharide derivatives
ribitol phosphate
ribitol
Prior art date
Application number
DK00956040T
Other languages
Danish (da)
English (en)
Inventor
Bencomo Vicente Guillerm Verez
Rene Roy
Original Assignee
Univ Ottawa
Univ La Habana
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Ottawa, Univ La Habana filed Critical Univ Ottawa
Application granted granted Critical
Publication of DK1212334T3 publication Critical patent/DK1212334T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/102—Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02—Acyclic radicals, not substituted by cyclic structures
    • C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02—Acyclic radicals, not substituted by cyclic structures
    • C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
    • C07H15/08—Polyoxyalkylene derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/18—Acyclic radicals, substituted by carbocyclic rings
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Saccharide Compounds (AREA)
DK00956040T 1999-08-30 2000-08-15 Oligosaccharidderivater fra ribose-ribitol-fosfat og vacciner indeholdende disse DK1212334T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CU1999121A CU22904A1 (es) 1999-08-30 1999-08-30 Oligosacáridos derivados de ribosa- ribitol-fosfato, métodos para prepararlos, inmunógenos que los comprenden y vacunas que comprenden dichos inmunógenos

Publications (1)

Publication Number Publication Date
DK1212334T3 true DK1212334T3 (da) 2006-03-20

Family

ID=5459405

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00956040T DK1212334T3 (da) 1999-08-30 2000-08-15 Oligosaccharidderivater fra ribose-ribitol-fosfat og vacciner indeholdende disse

Country Status (24)

Country Link
US (1) US6765091B1 (ru)
EP (1) EP1212334B1 (ru)
JP (1) JP4850377B2 (ru)
KR (1) KR100818163B1 (ru)
CN (1) CN1205217C (ru)
AR (1) AR025435A1 (ru)
AT (1) ATE308551T1 (ru)
AU (1) AU780816B2 (ru)
BR (1) BRPI0013686B8 (ru)
CA (1) CA2382602C (ru)
CO (1) CO5180646A1 (ru)
CU (1) CU22904A1 (ru)
CZ (1) CZ2002721A3 (ru)
DE (1) DE60023722T2 (ru)
DK (1) DK1212334T3 (ru)
EA (1) EA005381B1 (ru)
ES (1) ES2252045T3 (ru)
HK (1) HK1050693A1 (ru)
MX (1) MXPA02002066A (ru)
NZ (1) NZ517464A (ru)
SI (1) SI1212334T1 (ru)
UA (1) UA75579C2 (ru)
WO (1) WO2001016146A1 (ru)
ZA (1) ZA200201667B (ru)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1713508A2 (en) * 2004-01-29 2006-10-25 Biosynexus Incorporated Use of amino-oxy functional groups in the preparation of vaccine conjugates
US8647621B2 (en) 2009-07-27 2014-02-11 Fina Biosolutions, Llc Method of producing protein-carbohydrate vaccines reduced in free carbohydrate
RU2558257C2 (ru) 2009-07-31 2015-07-27 Нэшнл Рисерч Каунсл Оф Канада ВНЕШНИЙ КОРОВОЙ ЭПИТОП ЛИПОПОЛИСАХАРИДА Н. pylori
US9044517B2 (en) 2009-12-17 2015-06-02 Fina Biosolutions, Llc Activation of polysaccharides via the cyanylating agent, 1-cyano-4-pyrrolidinopyridinium tetrafluoroborate (CPPT), in the preparation of polysaccharide/protein conjugate vaccines
WO2011133191A1 (en) * 2010-04-23 2011-10-27 Serum Institute Of India, Ltd. Simple method for simultaneous removal of multiple impurities from culture supernatants to ultralow levels
JP6784841B2 (ja) 2016-07-28 2020-11-11 マックス プランク ゲゼルシャフト ツゥアー フェデルゥン デル ヴィッセンシャフテン エー フォー ヘモフィルス属インフルエンザ菌ｂ型に対するワクチンとしての安定した加水分解耐性合成ポリリボシルリビトールホスフェート誘導体
KR20200141053A (ko) * 2018-03-23 2020-12-17 코라넥스 캐피탈 치료 도구로서의 정밀 당 접합체

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ223009A (en) * 1986-12-31 1990-06-26 Nl Rivm Of Thoven Oligosaccharides containing d-ribose d-ribitol and phosphate units mimicing haemophilus influenzae type b antigens
EP0320942A3 (en) * 1987-12-18 1989-10-04 American Cyanamid Company Novel polysaccharides novel macromolecular conjugates of the polysaccharides
US5843463A (en) * 1990-12-21 1998-12-01 Antexbiologics, Inc. Adhesin-oligosaccharide conjugate vaccine for Haemophilus influenzae

Also Published As

Publication number Publication date
CA2382602A1 (en) 2001-03-08
JP2003528032A (ja) 2003-09-24
CN1376158A (zh) 2002-10-23
AR025435A1 (es) 2002-11-27
EP1212334B1 (en) 2005-11-02
CZ2002721A3 (cs) 2002-07-17
MXPA02002066A (es) 2004-07-30
NZ517464A (en) 2004-03-26
KR100818163B1 (ko) 2008-03-31
CN1205217C (zh) 2005-06-08
JP4850377B2 (ja) 2012-01-11
BRPI0013686B1 (pt) 2016-07-26
WO2001016146A1 (es) 2001-03-08
ES2252045T3 (es) 2006-05-16
AU6817300A (en) 2001-03-26
EA005381B1 (ru) 2005-02-24
CU22904A1 (es) 2004-01-23
EA200200314A1 (ru) 2002-10-31
HK1050693A1 (en) 2003-07-04
EP1212334A1 (en) 2002-06-12
DE60023722D1 (de) 2005-12-08
BRPI0013686B8 (pt) 2021-05-25
UA75579C2 (en) 2006-05-15
US6765091B1 (en) 2004-07-20
DE60023722T2 (de) 2006-07-20
ATE308551T1 (de) 2005-11-15
SI1212334T1 (sl) 2006-04-30
AU780816B2 (en) 2005-04-21
CO5180646A1 (es) 2002-07-30
CA2382602C (en) 2010-02-16
BR0013686A (pt) 2002-08-13
KR20020068501A (ko) 2002-08-27
ZA200201667B (en) 2003-08-27

Similar Documents

Publication Publication Date Title
NO20016277D0 (no) Systemer og fremgangsmåter for aerolisering av farmasöytiske formuleringer
DK1112251T3 (da) Azetidinderivater, deres fremstilling og medikamenter indeholdende disse derivater
IS6264A (is) Arýlmetýl-karbónýlamínó-þíósól afleiður og notkunþeirra sem miðla gegn æxlum
DK1454907T3 (da) Quninazolin og pyridopyrmidin-derivativer
DK1329456T3 (da) Glucopyranosyloxybenzylbenzenderivater og medicinske sammensætninger indeholdende samme
NO20002359L (no) Adenosinderivater og farmasoytisk sammensetning inneholdende derivatene
NO20021401D0 (no) Konazolinforbindelser og farmasöytiske preparater inneholdende slike forbindelser
NO20025154L (no) Imidazopyrimidinderivater og triazolpyrimidinderivater
NO20005026L (no) Anordning og fremgangsmåte for partikkelmåling
NO20000011D0 (no) Skumdempersammensetninger og fremgangsmåter
NO2011002I2 (no) Regadenoson og salter derav
NO985278L (no) Elektromagnetiske-til-akustiske og akustiske-til-elektro-magnetiske forsterkere og fremgangsmÕter for bruk av disse
DK1206281T3 (da) Formulering indeholdende moxifloxacin og natriumchlorid
DK199900176U3 (da) Paroxetinsalte, farmaceutisk præparat indeholdende disse og anvendelser deraf
DE50013828D1 (de) Differenzverstärker
NO20011943L (no) Forhjulsoppheng for busser og lignende
NO20000188D0 (no) Fremgangsmåte og anordning for sidebroenntilknytning
NO20015659D0 (no) Purinderivater, fremstillingsmetode og farmasöytiske preparater inneholdende disse
NO20013318L (no) Substituerte 2-aryliminoheterocykliske forbindelser og preparater inneholdende disse for anvendelse
NO991278L (no) FremgangsmÕte og system for sikker netthandel
DK1212334T3 (da) Oligosaccharidderivater fra ribose-ribitol-fosfat og vacciner indeholdende disse
NO991577D0 (no) FremgangsmÕte og system for testing av borehull
DE60032898D1 (de) Arylthiazolidindion- und aryloxazolidinderivate
DK1066261T3 (da) Pyridinderivat og farmaceutisk præparat indeholdende samme
DE60022934D1 (de) Verstärkerschaltungsanordnung